Literature DB >> 2956061

Memory impairment associated with progression of Huntington's disease.

S J Huber, G W Paulson.   

Abstract

Huntington's Disease (HD) has been described as one example of a "subcortical" dementia, characterized by slowed cognitive processing and impairment of memory. We examined the relationship between slowed cognitive processing and memory impairment as a function of disease progression in patients with HD. Results from three experiments suggest that in the early stages of HD there is slowed cognition with intact memory acquisition and retrieval processes. In later stages, cognition is further slowed and specific impairments of memory become evident. Thus, memory impairment in HD would appear to change qualitatively with progression of the disease.

Entities:  

Mesh:

Year:  1987        PMID: 2956061     DOI: 10.1016/s0010-9452(87)80037-0

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  4 in total

1.  Executive dysfunction in subcortical ischaemic vascular disease.

Authors:  J H Kramer; B R Reed; D Mungas; M W Weiner; H C Chui
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Modelling neural correlates of working memory: a coordinate-based meta-analysis.

Authors:  C Rottschy; R Langner; I Dogan; K Reetz; A R Laird; J B Schulz; P T Fox; S B Eickhoff
Journal:  Neuroimage       Date:  2011-12-01       Impact factor: 6.556

3.  Neuropsychological characteristics of Huntington's disease carriers: a double blind study.

Authors:  N K Rosenberg; S A Sørensen; A L Christensen
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

4.  Activating mitochondrial function and haemoglobin expression with EH-201, an inducer of erythropoietin in neuronal cells, reverses memory impairment.

Authors:  Lin-Yea Horng; Pei-Lun Hsu; Li-Wen Chen; Wang-Zou Tseng; Kai-Tin Hsu; Chia-Ling Wu; Rong-Tsun Wu
Journal:  Br J Pharmacol       Date:  2015-08-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.